NCT00016549 2017-07-02
Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)